Abstract
A group of 43 healthy neonates born from HBsAg-positive mothers were evaluated for the presence of protective HBsAb titre after administration of hepatitis B plasma-derived vaccine and hepatitis B hyperimmune-globulin. At 36 months of life we found that a significant number of children had a low HBsAb serum level. This suggests that a close serologic follow-up is necessary to evaluate the optimal timing for the administration of a booster dose of the vaccine.
Original language | English |
---|---|
Pages (from-to) | 195-198 |
Number of pages | 4 |
Journal | Microbiologica |
Volume | 14 |
Issue number | 3 |
Publication status | Published - Jul 1991 |
ASJC Scopus subject areas
- Applied Microbiology and Biotechnology